RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of ...
HSBC is preparing to wind down its M&A and equity capital markets businesses in Europe, the UK and the Americas as part of a ...
RBC Capital analyst Jonathan Atkin maintained a Hold rating on Verizon (VZ – Research Report) on January 24 and set a price target of $42.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback